Publication:
SAMe-TT<inf>2</inf>R<inf>2</inf> score for prediction of suboptimal time in therapeutic range in a Thai population with atrial fibrillation

dc.contributor.authorRungroj Krittayaphongen_US
dc.contributor.authorArjbordin Winijkulen_US
dc.contributor.authorAtthasit Pirapatditen_US
dc.contributor.authorPollakrit Chiewviten_US
dc.contributor.authorChulalak Komoltrien_US
dc.contributor.authorWarangkna Boonyapisiten_US
dc.contributor.authorSuchart Arunsiriwattanaen_US
dc.contributor.authorTanita Bunyapipaten_US
dc.contributor.authorSirin Apiyasawaten_US
dc.contributor.authorKasem Rattanasumawongen_US
dc.contributor.authorAhthit Yindeengamen_US
dc.contributor.otherRamathibodi Hospitalen_US
dc.contributor.otherSiriraj Hospitalen_US
dc.contributor.otherLampang Hospitalen_US
dc.contributor.otherPolice General Hospitalen_US
dc.contributor.otherSurat Thani Hospitalen_US
dc.date.accessioned2022-08-04T09:05:58Z
dc.date.available2022-08-04T09:05:58Z
dc.date.issued2021-12-01en_US
dc.description.abstractINTRODUCTION International normalised ratio (INR) control is an important factor in patients with non-valvular atrial fibrillation (NVAF) being treated with warfarin. INR control was previously reported to be poorer among Asians compared to Westerners. We aimed to validate the SAMe-TT2R2 score for prediction of suboptimal INR control (defined as time in therapeutic range [TTR] < 65% in the Thai population) and to investigate TTR among Thai NVAF patients being treated with warfarin. METHODS INR data from patients enrolled in a multicentre NVAF registry was analysed. Clinical and laboratory data was prospectively collected. TTR was calculated using the Rosendaal method. Baseline data was compared between patients with and without suboptimal INR control. Univariate and multivariate analyses were performed to identify variables independently associated with suboptimal INR control. RESULTS A total of 1,669 patients from 22 centres located across Thailand were included. The average age was 69.1 ± 10.7 years, and 921 (55.2%) were male. The mean TTR was 50.5% ± 27.5%; 1,125 (67.4%) had TTR < 65%. Univariate analysis showed hypertension, diabetes mellitus, heart failure, renal disease and SAMe-TT2R2 score to be significantly different between patients with and without optimal TTR. The SAMe-TT2R2 score was the only factor that remained statistically significant in multivariate analysis. The C-statistic for the SAMe-TT2R2 score in the prediction of suboptimal TTR was 0.54. CONCLUSION SAMe-TT2R2 score was the only independent predictor of suboptimal TTR in NVAF patients being treated with warfarin. However, due to the low C-statistic, the score may have limited discriminative power.en_US
dc.identifier.citationSingapore Medical Journal. Vol.61, No.12 (2021), 641-646en_US
dc.identifier.doi10.11622/SMEDJ.2019143en_US
dc.identifier.issn00375675en_US
dc.identifier.other2-s2.0-85099943013en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/77641
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85099943013&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleSAMe-TT<inf>2</inf>R<inf>2</inf> score for prediction of suboptimal time in therapeutic range in a Thai population with atrial fibrillationen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85099943013&origin=inwarden_US

Files

Collections